These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

213 related items for PubMed ID: 7919235

  • 21. Effects of chemotherapy (busulfan-hydroxyurea) and interferon-alfa on bone marrow morphologic features in chronic myelogenous leukemia. Histochemical and morphometric study on sequential trephine biopsy specimens with special emphasis on dynamic features.
    Thiele J, Kvasnicka HM, Schmitt-Graeff A, Bundschuh S, Biermann T, Roessler G, Wasmus M, Diehl V, Zankovich R, Schaefer HE.
    Am J Clin Pathol; 2000 Jul; 114(1):57-65. PubMed ID: 10884800
    [Abstract] [Full Text] [Related]

  • 22. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia.
    Carella AM, Chimirri F, Podestà M, Pitto A, Piaggio G, Dejana A, Lerma E, Pollicardo N, Vassallo F, Soracco M, Benvenuto F, Valbonesi M, Carlier P, Vimercati R, Prencipe E, Gatti AM, Ferrara RA, Incagliato M, Florio G, Frassoni F.
    Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167
    [Abstract] [Full Text] [Related]

  • 23. [Treatment of chronic myeloid leukemia using alpha-interferon and hydroxyurea. Study of 30 cases].
    Nese M, de Bellis R, Urtiarte R, Di Landro J.
    Sangre (Barc); 1994 Jun; 39(3):183-6. PubMed ID: 7940047
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Interferon treatment in chronic myeloid leukemia].
    Simonsson B.
    Nord Med; 1992 Jun; 107(3):76-7, 79. PubMed ID: 1549456
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Chronic myelogenous leukemia: progress in chemotherapy and evaluation of prognostic score 1. The German CML Study Group.
    Hehlmann R, Ansari H, Hasford J, Heimpel H.
    Semin Hematol; 1993 Jul; 30(3 Suppl 3):44-8. PubMed ID: 8235707
    [No Abstract] [Full Text] [Related]

  • 28. [Recent progress in therapy for chronic myelogenous leukemia].
    Urabe A.
    Gan To Kagaku Ryoho; 1997 Jul; 24(9):1066-73. PubMed ID: 9239158
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Current controversies on the role of interferon-alpha for therapy of chronic myeloid leukemia.
    Heimpel H, Allan NC, Baccarani M, Guilhot F, Hehlmann R, Horowitz M, Kluin-Nelemans J, Schaefer U, Storb R, Thaler J.
    Bone Marrow Transplant; 1996 May; 17 Suppl 3():S39. PubMed ID: 8769699
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [Developments in the treatment of patients with chronic myeloid leukemia].
    Cornelissen JJ, Löwenberg B.
    Ned Tijdschr Geneeskd; 1997 Oct 04; 141(40):1904-9. PubMed ID: 9550736
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Intensive treatment in order to minimize the Ph-positive clone in CML. Danish-Swedish CML Group.
    Simonsson B, Oberg G, Björeman M, Björkholm M, Carneskog J, Gahrton G, Hast R, Karl H, Lanng-Nielsen J, Löfvenberg E, Malm C, Turesson I, Udén AM, Vilén L, Weis-Bjerrum O.
    Bone Marrow Transplant; 1996 May 04; 17 Suppl 3():S63-4. PubMed ID: 8769705
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.